Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
CVIR Endovasc ; 6(1): 45, 2023 Sep 09.
Article in English | MEDLINE | ID: mdl-37688689

ABSTRACT

BACKGROUND: Though fracture is known complication of stenting, pseudoaneurysm asscoiated with stent fracture is an extremely rare complication. This has previoulsy been described to occur at least one or more years following initial stent placement. Here we present a case of multi-site stent fracture leading to two separate SFA pseudoaneurysms within one year of placement, successfully treated with covered stents. CASE PRESENTATION: A 72-year-old male presented with severe claudication of his left lower extremity (Rutherford 3), found to have long segment SFA chronic total occlusion (CTO). Patient successfully underwent endovascular revascularization. Follow-up duplex ultrasound (US) at one year demonstrated a focus of severe in-stent restenosis (ISR). During repeat angiogram for treatment of the stenosis, stent fracture and pseudoaneurysm was seen in the distal SFA, which was treated successfully with a self-expanding covered stent. Additional stent fractures and pseudoanerusyms were subseuqently identified on follow-up, necessitating a third angiogram, and these were successfully repaired using overlapping covered stents, without further recurrence. CONCLUSIONS: Superficial femoral artery stent fractures leading to pseudoaneurysms are extremely rare, particularly within first year of stent placement. Endovascular repair with covered stents has proven to be an effective treatment option with decreased procedural morbidity compared to surgical repair.

2.
Radiol Case Rep ; 13(2): 392-396, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29904480

ABSTRACT

Primitive neuroectodermal tumor is a high-grade malignant tumor originating from the neural crest and neuroectoderm, which can be subdivided into central and peripheral categories. Peripheral primitive neuroectodermal tumor is thought to be identical to Ewing's sarcoma, and falls under a broader category of Ewing's sarcoma family of tumors. Very rarely, it may present without osseous involvement, known as extraosseous Ewing's sarcoma. Here we present a case of a 38-year-old woman, who presented with several-month history of a slow-growing chest wall mass, initially thought to be a breast mass. The mass was diagnosed as extraosseous Ewing's sarcoma upon tissue biopsy. The patient was started on a dose-intensified neoadjuvant therapy, based on protocol from pediatric population given rarity of this tumor in the adult population. While the patient was initially planned for surgical resection, the tumor showed excellent response to chemotherapy on follow-up imaging, and radiation therapy was elected in lieu of resection.

3.
Case Rep Orthop ; 2015: 690159, 2015.
Article in English | MEDLINE | ID: mdl-26090254

ABSTRACT

Case. A right-handed 8-year-old female patient presented with a conventional, high-grade osteosarcoma involving her right humerus; through-shoulder amputation was recommended. After consultation, total humerus resection with expandable, total humeral endoprosthesis reconstruction was performed with a sleeve to encourage soft-tissue ingrowth. At three-year follow-up she has received one lengthening procedure and her functional scores are excellent. Conclusion. Total humeral resection and replacement in the pediatric population are rare and although early reports of expandable total humeral endoprosthesis outcomes demonstrate high failure rates, this patient's success indicates that expandable total humeral replacement is a viable option.

4.
FEBS Lett ; 587(24): 3961-7, 2013 Dec 11.
Article in English | MEDLINE | ID: mdl-24188826

ABSTRACT

To investigate the effects of histone methyltransferase ESET (also known as SETDB1) on bone metabolism, we analyzed osteoblasts and osteoclasts in ESET knockout animals, and performed osteogenesis assays using ESET-null mesenchymal stem cells. We found that ESET deletion severely impairs osteoblast differentiation but has no effect on osteoclastogenesis, that co-transfection of ESET represses Runx2-mediated luciferase reporter while siRNA knockdown of ESET activates the luciferase reporter in mesenchymal cells, and that ESET is required for postnatal expression of Indian hedgehog protein in the growth plate. As the bone phenotype in ESET-null mice is 100% penetrant, these results support ESET as a critical regulator of osteoblast differentiation during bone development.


Subject(s)
Bone Development/genetics , Cell Differentiation/genetics , Histone-Lysine N-Methyltransferase/physiology , Mesenchymal Stem Cells/physiology , Osteoblasts/physiology , Animals , Animals, Newborn , Bone Development/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Core Binding Factor Alpha 1 Subunit/physiology , Histone-Lysine N-Methyltransferase/antagonists & inhibitors , Mesenchymal Stem Cells/drug effects , Mice , Mice, Knockout , Osteoblasts/drug effects , Osteoclasts/drug effects , Osteoclasts/physiology , Osteogenesis/drug effects , Osteogenesis/genetics , RNA, Small Interfering/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...